Ingredient Spotlight26 Sep 20266 min readUpdated 26 Sep 2026

Glutathione in skin care: what the evidence shows for brightening

Glutathione is a popular brightening ingredient, but topical trials are few and small. CSL formulation scientists explain what the evidence supports and how to keep this easily oxidised tripeptide stable.

By CSL Formulation team · Evidence checked by CSL scientists

Ingredient guideEvidence: Limited
Glutathione (GSH), the tripeptide gamma-glutamyl-cysteinyl-glycine, C10H17N3O6S, 307.32 g/mol: its chemical structure on a glass panel beside white glutathione powder in a glass dish and a serum dropper bottle, with a woman with radiant skin in the background

At a glance

What it is
A tripeptide antioxidant made by the body, used in cosmetics as reduced glutathione (GSH) or oxidised glutathione (GSSG)
Main benefits
Brighter, more even-looking tone; some data on smoother-looking, better-hydrated skin
Levels tested in trials
2% oxidised glutathione lotion; 2% reduced glutathione gel; oral trials used 250 mg a day
Time to results
10 to 12 weeks in controlled studies
Watch for
Rapid oxidation, odour, thin topical evidence and confusion with unapproved injectable use

01What is it?

Glutathione is a small peptide made of three amino acids. It is the body’s main internal antioxidant and occurs in every cell. In cosmetics it is used in its reduced form (GSH) or its more stable oxidised form (GSSG). It is especially popular in India, South-East Asia and the Gulf markets.

02What it does

Glutathione is thought to shift melanin production from darker eumelanin towards lighter pheomelanin and to dampen the oxidative stress that drives pigmentation. In one placebo-controlled study a 2% oxidised glutathione lotion lowered measured melanin over 10 weeks and improved skin moisture and smoothness. Effects in trials have been modest and, for oral use, did not last after stopping.

03The evidence

Strength of human evidenceLimited: one small placebo-controlled topical trial and one open-label trial; reviews call the overall evidence weak and mostly oral

Studies below were checked against the publisher, DOI or journal record on 26 Sep 2026. We list design and size so you can judge the strength of each result.

StudyDesignWho and how longWhat it found
Watanabe et al. 2014, Clinical, Cosmetic and Investigational Dermatology (Dove Press)
Source
Randomised, double-blind, matched-pair, placebo-controlled trial30 healthy women aged 30–50, 10 weeks, 2% oxidised glutathione lotion twice daily on one side of the face vs placeboMelanin index was significantly lower than placebo from early weeks to the end of the study (p < 0.001 at 10 weeks), with better moisture, smoothness and fewer visible wrinkles later in the study; no marked side effects.
Bijalwan et al. 2024, JK Science (smaller regional journal)
Source
Randomised, open-label, parallel trial against 3% tranexamic acid60 adults with melasma, 90 days, 2% reduced glutathione gel twice daily vs 3% tranexamic acidMelasma score fell 67% with glutathione vs 44% with tranexamic acid (p = 0.009); mild redness in 2 of 30. Not blinded and in a smaller journal, so weaker evidence.
Weschawalit et al. 2017, Clinical, Cosmetic and Investigational Dermatology (Dove Press) – oral, for context
Source
Randomised, double-blind, placebo-controlled, three-arm trial60 healthy adults (57 completed), 12 weeks, oral reduced or oxidised glutathione 250 mg a day vs placeboOverall melanin differences versus placebo were not significant; melanin was lower only on sun-exposed forearms in people over 40 (p = 0.031). Two people had temporary rises in liver enzymes.
Sitohang and Ninditya 2020, Dermatology Research and Practice (Hindawi) – oral, for context
Source
Evidence-based systematic review3 randomised trials of oral glutathione, 32 to 60 participants eachConcluded oral glutathione is not beneficial enough for skin lightening: effects appeared only on some body sites and did not last (in one trial no difference 6 months after stopping).
Sonthalia et al. 2018, Dermatology Practical & Conceptual
Source
Narrative evidence reviewPublished trials of topical, oral, sublingual and intravenous glutathioneFound one topical trial with good safety and appreciable but reversible effects on skin tone; judged evidence for intravenous use limited to a single flawed study.
Alzahrani et al. 2025, Cureus (Springer Nature)
Source
Narrative reviewTopical, oral and intravenous glutathione studiesTopical forms lowered melanin with minimal, self-resolving side effects; oral effects were measurable but inconsistent; intravenous use carried risks such as anaphylaxis and liver toxicity.
CSL verdict

Topical glutathione may modestly brighten skin, but the evidence rests on one small placebo-controlled study and one unblinded trial. Its popularity is far ahead of its evidence. Suitable claim wording is cautious, such as “helps skin look brighter and more even”, ideally supported by the brand’s own instrumental study.

04How CSL formulation scientists use it

  • Choose the form deliberately: oxidised glutathione (GSSG) is more stable in water than reduced glutathione (GSH) and is the form with the placebo-controlled topical data, at 2%.
  • Reduced glutathione oxidises quickly in water, especially at higher pH, with metal ions and with air. CSL formulation scientists use chelators, low-oxygen processing, airless or single-dose packs, and anhydrous or encapsulated formats, and run real-time stability with assay of the active, not only appearance.
  • Sulphur-containing glutathione can develop an odour as it breaks down; fragrance and pack choice need testing in the finished product.
  • Pair it with better-evidenced brightening actives such as niacinamide, tranexamic acid or vitamin C derivatives, and daily sun protection, rather than relying on glutathione alone.

05Regulatory and claims

CSL works only on topical cosmetic formats. Injectable and intravenous glutathione for skin whitening is not an approved use: the Philippine health authorities have stated that intravenous glutathione is not approved for skin whitening, and in August 2026 the US FDA warned compounders not to use dietary-supplement-grade glutathione in injectables after at least 30 people had serious reactions. CSL regulatory specialists confirm the status of glutathione in each target market, including India, ASEAN and the GCC, and keep claims cosmetic (“brighter-looking skin”), never “whitening treatment” or “treats melasma”.

06Questions brands ask

Does topical glutathione really brighten skin?

There is some evidence. A 2% oxidised glutathione lotion lowered measured melanin versus placebo over 10 weeks in 30 women. That is one small study, so claims should stay modest.

Is oral glutathione better than topical?

Not clearly. Oral trials show small effects on some skin areas that fade after stopping, and a systematic review judged them not beneficial enough. CSL focuses on topical cosmetic products.

Why does glutathione go off in formulas?

The reduced form reacts readily with oxygen and metal traces, losing activity and sometimes developing an odour. The oxidised form, careful processing and protective packaging help keep it stable.

07References

  1. Watanabe F, Hashizume E, Chan GP, Kamimura A. Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women. Clin Cosmet Investig Dermatol. 2014;7:267–274. Link
  2. Bijalwan S, Randhawa GK, Kaur T. A prospective, randomized and open label study to compare efficacy, safety and quality of life impact of topical glutathione (2%) in comparison to topical tranexamic acid (3%) in adult melasma patients. JK Science. 2024;26(3):149–154. Link
  3. Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol. 2017;10:147–153. Link
  4. Sitohang IBS, Ninditya S. Systemic glutathione as a skin-whitening agent in adult. Dermatol Res Pract. 2020;2020:8547960. Link
  5. Sonthalia S, Jha AK, Lallas A, Jain G, Jhakar D. Glutathione for skin lightening: a regnant myth or evidence-based verity? Dermatol Pract Concept. 2018;8(1). Link
  6. Alzahrani et al. Exploring the safety and efficacy of glutathione supplementation for skin lightening: a narrative review. Cureus. 2025;17:e78045. Link
  7. US Food and Drug Administration. FDA reminds compounders not to use dietary supplement grade glutathione for injectables. 27 August 2026. Link
  8. Philippine Daily Inquirer. DOH warns against use of intravenous glutathione for skin whitening. Link
CSL
Develop a product with glutathioneCSL formulation scientists match the form, level and claims to your markets.Start a project

Used in: Brightening & radiance

Update log

  • Evidence reviewed and page published by CSL scientists

This page summarises published research for brands and formulators. It is general information, not medical advice, and results in studies depend on the full formula tested.

Regulatory watch newsletter

Rule changes, before they hit your label.

A monthly email on new ingredient restrictions, MoCRA updates and market deadlines. Plus our free guides and webinar invitations.

Start a project

Create your next product with CSL.

Our formulation chemists, testing scientists and regulatory specialists work alongside your team, from the first brief to a market-ready product. Bring a brief, a benchmark or just an idea: a scientist will reply within one working day with next steps and an indicative scope.

Create with us